CHARLOTTE, N.C., July 16, 2024 /PRNewswire/ — Bank of America reported its second quarter 2024 financial results today. The news release, supplemental filing and investor presentation can be accessed at Bank of America’s Investor Relations website at https://investor.bankofamerica.com/quarterly-earnings. Investor Conference Call information:Chief Executive Officer Brian Moynihan and Chief Financial Officer Alastair Borthwick will discuss the […]
Category Archives: Pr Newswire
MORRISVILLE, N.C., July 16, 2024 /PRNewswire/ — Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced the expansion of its metabolite library to include 70 pesticides, strengthening the company’s ability to provide comprehensive environmental exposure insights via metabolomics […]
SINGAPORE, July 16, 2024 /PRNewswire/ — Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China has approved the initiation of a pivotal Phase ll clinical trial evaluating BRG01, the company’s autologous Epstein-Barr virus […]
SHANGRAO, China, July 16, 2024 /PRNewswire/ — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that its indirectly majority-owned subsidiary, JinkoSolar Middle East DMCC (“Jinko Middle East“), has entered into a shareholders agreement (the “Agreement”) with Renewable Energy […]
SEOUL, South Korea, July 16, 2024 /PRNewswire/ — The 3rd AUTISM EXPO 2024 concluded on a high note, featuring a wide range of exhibits and diverse events that attracted enthusiastic participation from individuals with developmental disabilities, their families, and related organizations. 3rd AUTISM EXPO Concludes Successfully with Celebration and Unity Co-hosted by SurplusGLOBAL and the […]
16
Jul
Jul
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2024, before market open on Wednesday, August 7, 2024 and […]
Pr Newswire
CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024
16
Jul
Jul
MINNEAPOLIS, July 15, 2024 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular implantable neuromodulation device for patients with cardiovascular diseases, today announced that it plans to release second quarter 2024 financial and operating results after market close on Monday, July […]
16
Jul
Jul
SANTA CLARA, Calif., July 15, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2024 after market close on Monday, August 5, 2024. Management will host a corresponding conference call beginning […]
16
Jul
Jul
SAN DIEGO, July 15, 2024 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it received formal notice from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq’s minimum bid price […]
Pr Newswire
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
16
Jul
Jul
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that second quarter of fiscal year 2024 financial results will be reported after the […]